Displaying 1–25 of 4007 results for

Sort By Relevance Sort By Date
1 2 3 4 5 ...161

Finalists announced for CPhI Worldwide Awards

(News)

CPhI Worldwide has revealed the finalists for the annual CPhI Pharma Awards.

Merck to lay off 500

(News)

Merck said it plans to eliminate approximately 500 jobs largely based out of Pennsylvania along with a small number of New Jersey positions.

Pharma in review: trending stories 10/18/19

(News)

pharma manufacturing news in review

FDA calls out Torrent as key contributor to major recall

(News)

The FDA has issued a warning letter to Torrent Pharmaceuticals and said the company is at the center of its investigation into a global recall of several blood pressure medications.

Report: Teva may donate $15B in generic drugs to resolve opioid lawsuits

(News)

With several major pharma companies staring down the start of a federal trial related to opioids, Teva Pharmaceuticals is reportedly looking to settle by donating $15 billion in drugs.

FDA hits Lupin, Aurobindo and Cipla with Form 483s

(News)

The FDA found issues related to cleanliness, out-of-specification results and more after several visits in September.

Sanofi opens next-generation biologics plant in Massachusetts

(News)

The French drugmaker is billing the feat as its first digitally-enabled, continuous manufacturing facility.

Takeda sheds Mideast, Africa portfolio

(News)

Japan’s largest drugmaker has struck a deal to sell a major part of its portfolio.

Cell therapy startup raises additional $16M in funding

(News)

Mogrify announced the initial close of its Series A funding, raising $16 million in this round, bringing the total investment to over $20 million to date.

Lily migraine drug wins FDA approval

(News)

The FDA has given the go-ahead to a new migraine treatment made by Eli Lily and Co.

PhRMA lashes out against Pelosi drug pricing bill

(News)

The CEO of the biggest pharma industry lobbying group has warned that Speaker Nancy Pelosi's bill to lower drug prices would have a “devastating” effect on the industry.

BeiGene builds China biopharma base

(News)

BeiGene, announced the completion of Phase 1 of a more than 1,000,000 square foot biomanufacturing facility in Guangzhou, China.

J&J offloads non-opioid analgesic

(News)

Neumentum has entered into a global licensing agreement with J&J's Janssen Pharmaceuticals for the rights to novel oral analgesic candidate, JNJ-10450232.

Pharma in review: trending stories 10/11/19

(News)

pharma manufacturing news in review

Clinuvel cinches FDA nod for rare skin disease drug

(News)

For the first time ever, patients in the U.S. with a rare but painful skin disease will have access to an FDA-approved treatment.

Jury awards man $8B for claims a J&J drug made him grow breasts

(News)

A Philadelphia jury has ordered Johnson & Johnson to pay a whopping $8 billion for a claim that the company failed to warn patients about serious side effects associated with an anti-psychotic drug.

Arizona backtracks on Purdue opioid settlement

(News)

Last month 24 states and local governments reached a deal that was speculated to be worth more than $10 billion.

Novartis blockbuster eye med wins FDA approval

(News)

Beovu injections treat wet age-related macular degeneration that affects 20 million people worldwide, according to the company.

Gilead gets 2nd HIV drug approved for PrEP

(News)

The U.S. FDA approved Gilead Sciences' Descovy for pre-exposure prophylaxis, or PrEP, among male adults and adolescents who are HIV-negative and considered to be at risk for sexually acquired HIV.

Glenmark receives FDA warning letter for Baddi plant

(News)

Mumbai-based Glenmark Pharmaceuticals has been issued an FDA warning letter for manufacturing issues at its Baddi plant.

J&J grabs Bayer exec as new CIO

(News)

Johnson & Johnson has hired a former Bayer executive as its chief information officer.

Pfizer inks antisense drug deal worth up to $1.5B

(News)

Pfizer will front $250 million to gain rights to a phase 2 drug being developed to target a range of major diseases. Pfizer will front $250 million to gain rights to a phase 2 drug being developed to target a range of major diseases.

Pharma in review: trending stories 10/4/19

(News)

pharma manufacturing news in review

Universities took millions in gifts from Sackler family

(News)

Prestigious universities around the world have accepted at least $60 million in donations over the past five years from the family that owns Purdue Pharma, even as the drugmaker became entangled in lawsuits related to the opioid epidemic.

J&J settles Ohio opioid lawsuits for $20.4M

(News)

Johnson & Johnson has agreed to a $20.4 million settlement to avoid going to trial over the opioid-addiction crisis in two Ohio counties.

Sort By Relevance Sort By Date
1 2 3 4 5 ...161